Uppsala, Sweden

Magnus Thöm


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Magnus Thöm - Pioneering Cancer Treatment with T-Lymphocytes

Introduction: Magnus Thöm, a visionary inventor hailing from Uppsala, Sweden, has revolutionized the field of oncology with his groundbreaking patent on treating colon cancer using tumour-reactive T-lymphocytes.

Latest Patents: Magnus Thöm holds a pivotal patent for a method involving expanded tumour-reactive CD4+ helper and/or CD8+ T-lymphocytes obtained from sentinel or metinel lymph nodes draining colon tumours, offering a novel and effective treatment for colon cancer and metastases.

Career Highlights: Magnus Thöm is a key figure at Sentoclone International Ab, a cutting-edge company at the forefront of immunotherapeutic research and development. His expertise in cancer treatment has brought significant advancements to the medical industry.

Collaborations: Among Magnus Thöm's colleagues is Ola Winqvist, a collaborator who has worked alongside him in the innovative field of immunotherapy for cancer. Together, they continue to push the boundaries of medical science.

Conclusion: Magnus Thöm's dedication to improving cancer care through pioneering immunotherapeutic approaches underscores his invaluable contributions to the medical community. His patent stands as a testament to his commitment to advancing the field of oncology and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…